Cargando…
A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation
BACKGROUND: Artificial intelligence (AI) algorithms are capable of automatically detecting contouring boundaries in medical images. However, the algorithms impact on clinical practice of cervical cancer are unclear. We aimed to develop an AI-assisted system for automatic contouring of the clinical t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667653/ https://www.ncbi.nlm.nih.gov/pubmed/36380378 http://dx.doi.org/10.1186/s13014-022-02157-5 |
_version_ | 1784831764486684672 |
---|---|
author | Nie, Shihong Wei, Yuanfeng Zhao, Fen Dong, Ya Chen, Yan Li, Qiaoqi Du, Wei Li, Xin Yang, Xi Li, Zhiping |
author_facet | Nie, Shihong Wei, Yuanfeng Zhao, Fen Dong, Ya Chen, Yan Li, Qiaoqi Du, Wei Li, Xin Yang, Xi Li, Zhiping |
author_sort | Nie, Shihong |
collection | PubMed |
description | BACKGROUND: Artificial intelligence (AI) algorithms are capable of automatically detecting contouring boundaries in medical images. However, the algorithms impact on clinical practice of cervical cancer are unclear. We aimed to develop an AI-assisted system for automatic contouring of the clinical target volume (CTV) and organs-at-risk (OARs) in cervical cancer radiotherapy and conduct clinical-based observations. METHODS: We first retrospectively collected data of 203 patients with cervical cancer from West China Hospital. The proposed method named as SegNet was developed and trained with different data groups. Quantitative metrics and clinical-based grading were used to evaluate differences between several groups of automatic contours. Then, 20 additional cases were conducted to compare the workload and quality of AI-assisted contours with manual delineation from scratch. RESULTS: For automatic CTVs, the dice similarity coefficient (DSC) values of the SegNet trained with incorporating multi-group data achieved 0.85 ± 0.02, which was statistically better than the DSC values of SegNet independently trained with the SegNet((A)) (0.82 ± 0.04), SegNet((B)) (0.82 ± 0.03) or SegNet((C)) (0.81 ± 0.04). Moreover, the DSC values of the SegNet and UNet, respectively, 0.85 and 0.82 for the CTV (P < 0.001), 0.93 and 0.92 for the bladder (P = 0.44), 0.84 and 0.81 for the rectum (P = 0.02), 0.89 and 0.84 for the bowel bag (P < 0.001), 0.93 and 0.92 for the right femoral head (P = 0.17), and 0.92 and 0.91 for the left femoral head (P = 0.25). The clinical-based grading also showed that SegNet trained with multi-group data obtained better performance of 352/360 relative to it trained with the SegNet((A)) (334/360), SegNet((B)) (333/360) or SegNet((C)) (320/360). The manual revision time for automatic CTVs (OARs not yet include) was 9.54 ± 2.42 min relative to fully manual delineation with 30.95 ± 15.24 min. CONCLUSION: The proposed SegNet can improve the performance at automatic delineation for cervical cancer radiotherapy by incorporating multi-group data. It is clinically applicable that the AI-assisted system can shorten manual delineation time at no expense of quality. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-022-02157-5. |
format | Online Article Text |
id | pubmed-9667653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96676532022-11-17 A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation Nie, Shihong Wei, Yuanfeng Zhao, Fen Dong, Ya Chen, Yan Li, Qiaoqi Du, Wei Li, Xin Yang, Xi Li, Zhiping Radiat Oncol Research BACKGROUND: Artificial intelligence (AI) algorithms are capable of automatically detecting contouring boundaries in medical images. However, the algorithms impact on clinical practice of cervical cancer are unclear. We aimed to develop an AI-assisted system for automatic contouring of the clinical target volume (CTV) and organs-at-risk (OARs) in cervical cancer radiotherapy and conduct clinical-based observations. METHODS: We first retrospectively collected data of 203 patients with cervical cancer from West China Hospital. The proposed method named as SegNet was developed and trained with different data groups. Quantitative metrics and clinical-based grading were used to evaluate differences between several groups of automatic contours. Then, 20 additional cases were conducted to compare the workload and quality of AI-assisted contours with manual delineation from scratch. RESULTS: For automatic CTVs, the dice similarity coefficient (DSC) values of the SegNet trained with incorporating multi-group data achieved 0.85 ± 0.02, which was statistically better than the DSC values of SegNet independently trained with the SegNet((A)) (0.82 ± 0.04), SegNet((B)) (0.82 ± 0.03) or SegNet((C)) (0.81 ± 0.04). Moreover, the DSC values of the SegNet and UNet, respectively, 0.85 and 0.82 for the CTV (P < 0.001), 0.93 and 0.92 for the bladder (P = 0.44), 0.84 and 0.81 for the rectum (P = 0.02), 0.89 and 0.84 for the bowel bag (P < 0.001), 0.93 and 0.92 for the right femoral head (P = 0.17), and 0.92 and 0.91 for the left femoral head (P = 0.25). The clinical-based grading also showed that SegNet trained with multi-group data obtained better performance of 352/360 relative to it trained with the SegNet((A)) (334/360), SegNet((B)) (333/360) or SegNet((C)) (320/360). The manual revision time for automatic CTVs (OARs not yet include) was 9.54 ± 2.42 min relative to fully manual delineation with 30.95 ± 15.24 min. CONCLUSION: The proposed SegNet can improve the performance at automatic delineation for cervical cancer radiotherapy by incorporating multi-group data. It is clinically applicable that the AI-assisted system can shorten manual delineation time at no expense of quality. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13014-022-02157-5. BioMed Central 2022-11-15 /pmc/articles/PMC9667653/ /pubmed/36380378 http://dx.doi.org/10.1186/s13014-022-02157-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Nie, Shihong Wei, Yuanfeng Zhao, Fen Dong, Ya Chen, Yan Li, Qiaoqi Du, Wei Li, Xin Yang, Xi Li, Zhiping A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation |
title | A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation |
title_full | A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation |
title_fullStr | A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation |
title_full_unstemmed | A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation |
title_short | A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation |
title_sort | dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667653/ https://www.ncbi.nlm.nih.gov/pubmed/36380378 http://dx.doi.org/10.1186/s13014-022-02157-5 |
work_keys_str_mv | AT nieshihong adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT weiyuanfeng adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT zhaofen adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT dongya adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT chenyan adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT liqiaoqi adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT duwei adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT lixin adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT yangxi adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT lizhiping adualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT nieshihong dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT weiyuanfeng dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT zhaofen dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT dongya dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT chenyan dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT liqiaoqi dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT duwei dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT lixin dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT yangxi dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation AT lizhiping dualdeepneuralnetworkforautodelineationincervicalcancerradiotherapywithclinicalvalidation |